26
Jun
2008
Dear Cherished CLSDF Readers, It is with a crashing wave of mixed emotions that I report this to be my final post as author of CLSDF. It is nearly three years to the day and over 500 posts since CLSDF launched, first as an experiment in learning about the blogosphere and new technologies yet rapidly [...]
26
Jun
2008
Congratulations to GlobeImmune for being named to Fierce Biotech’s 2008 Fierce 15 List (click HERE for a link to see the other 15 companies)! What makes it Fierce: GlobeImmune’s third round of financing last fall was its biggest, $41.2M, bringing its total venture haul to north of $88M. Wexford capital led the round and Celgene, [...]
26
Jun
2008
Colorado: An Emerging Cluster!
Posted in My Rants
On the heels of last weeks publications from Families USA’s Global Health Initiative report, ranking Colorado No. 4 among states that generated the most economic activity per dollar of funding from the NIH, and the 2008 Milken Institute State Technology and Science Index ranking Colorado 3rd, trailing only Massachusetts and Maryland, based on technology and [...]
24
Jun
2008
BioBeers Tonight: Be There or Beware
Posted in BioBeers
But before you attend BioBeers be certain to attend the Colorado Bioscience Association BioBoulder Networking Reception 5:30 – 7:00 at Rembrandt Yard. More info (HERE). Then just when you think it is time to head home for dinner, enjoy a summer evening with the family and walk the dog beware, because it is actually time [...]
24
Jun
2008
An unfortunate day indeed as Replidyne (NASDAQ: RDYN) has terminated their licensing deal with Asubio Pharma for its lead drug candidate Faropenem and subsequently is expecting a charge of approximately $4.1M. Recall, Replidyne discontinued enrollment in a late-stage study testing its faropenem medoxomil oral antibiotic as a treatment for patients with acute chronic bronchitis due [...]
23
Jun
2008
Back in the Saddle…
Posted in My Rants
I’m playing catch-up today after attending the week long BIO2008 conference last week. It was an incredible experience (again) on a variety of levels and so too was the opportunity to again be an invited conference guest blogger. Despite the technological hurdles faced I was able to get to a few postings, here is a [...]
18
Jun
2008
Sitting in amazement of the logistical tango displayed by the BIO organizers on just exactly how does one feed 20,000+ attendees in a sophisticated and elegant manner, needless to say the Keynote Luncheon #1 was executed to perfection. Whilst hacking away at a blog post my PC endured the dreaded blue screen of death. What’s [...]
17
Jun
2008
Having evolved into now a BIO veteran has yielded some very important lessons for a successful conference, one in particular that has resonated is – wear comfortable shoes. There is a lot of walking to be done over the four days and therefore I have elected to choose function over fashion and swap out the [...]
17
Jun
2008
myBIO2008 Mobile = Value-add
Posted in My Rants
Technology has permeated all aspects of BIO2008, one of the coolest additions is the myBIO mobile addition, this offering may come in handy (pun intended) for all of you Blackberry and iPhone addicts. The value proposition is multifold, in the palm of your hand one may simply: Locate exhibitors and booth numbers Locate sessions (by [...]
13
Jun
2008
Follow Me on the BIO2008 Blog!
Posted in My Rants
And the new BIO2008 blog, BioOnTheRoad, is off to the races (http://BioOnTheRoad.org). I will be blogging there for the next week covering the BIO2008 conference live from San Diego. There will also be a blog feed to the conference homepage at http://BIO2008.org. Where appropriate I will cross blog certain posts. Right now you can subscribe [...]
12
Jun
2008
CLSDF: Subscriber Growth Update
Posted in My Rants
I am excited to announce CLSDF has added another 100 subscribers; the blog is now north of 500, passing the 400 mark only 3 months ago in March. My infinite appreciation to all of you for subscribing, your feedback (both positive and negative) is treasured and motivating. If you find CLSDF to be of continuing [...]
12
Jun
2008
Ceragenix Pilot Study Results for EpiCeram®
Posted in CO Pub Rel: Novartis, CO Public: Ceragenix Pharma
Ceragenix Pharmaceuticals (OTCBB: CGXP) announced positive results from its investigator-blinded pilot study comparing the safety and efficacy of EpiCeram® Skin Barrier Emulsion to that of Elidel® cream from Novartis (NYSE: NVS), a standard non-steroidal therapy in the treatment of mild-to-moderate pediatric atopic dermatitis (AD). Both EpiCeram® and Elidel® cream produced significant improvement in patients’ conditions [...]
10
Jun
2008
QLT, Inc. (NASDAQ: QLTI) announced that QLT USA, its wholly-owned subsidiary, has entered into an asset purchase agreement with Allergan (NYSE: AGN) to fully divest QLT’s worldwide rights to Aczone®, a prescription topical medicine approved in the United States and Canada for the treatment of acne vulgaris. Under the terms of the agreement, QLT will [...]
Life Science Deal Flow PARTNERS
-
